tapentadol hydrochloride · Medicine question

What does the product information state about pharmaceutical incompatibilities for Palexia SR 250 mg prolonged-release tablets containing tapentadol hydrochloride?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The product information for Palexia SR 250 mg prolonged-release tablets containing tapentadol hydrochloride states that pharmaceutical incompatibilities are “Not applicable”.

Sources for this answer

Palexia SR 250 mg prolonged-release tabletsGrunenthal Ltd · emc · SmPC §6.2 Incompatibilities · Version 10Document updated 13 January 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about tapentadol hydrochloride